Gambro equipment connected to patient deaths in Hong Kong following similar incident in the US
This article was originally published in Clinica
Executive Summary
Investigations are underway into the deaths of three patients in a private hospital in Hong Kong following treatment with Gambro's dialyser equipment. The incident comes three months after the company was forced to recall blood tubing after four patients died in the US. The company has also been hit by problems in its European factories, which have forced it to buy products from competitors.